News

Medical Device Network on MSN8d
Quest introduces blood test to confirm amyloid brain pathology in Alzheimer’s
Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related ...
Zacks Investment Research on MSN3d
Here's How Quest Diagnostics is Placed Ahead of Q1 Earnings
Quest Diagnostics DGX is set to release its first-quarter 2025 results on April 22, before the market opens. The renowned ...
Quest Diagnostics launches AD-Detect blood test for Alzheimer’s confirmation
Quest Diagnostics (DGX) launched a new laboratory blood test designed to help physicians confirm amyloid brain pathology due to Alzheimer’s ...
Nasdaq9d
Quest Diagnostics Launches New Blood Test To Confirm Alzheimer's Disease
(RTTNews) - Quest Diagnostics (DGX), Wednesday announced the launch of a new blood test designed to confirm amyloid brain pathology due to Alzheimer's disease (AD) in patients with mild cognitive ...
Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease
Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced the launch of a new laboratory blood test designed to help ...
Quest Diagnostics price target raised to $198 from $190 at BofA
BofA analyst Michael Ryskin raised the firm’s price target on Quest Diagnostics (DGX) to $198 from $190 and keeps a Buy rating on the shares.
Yahoo Finance16d
Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening
Quest Diagnostics Incorporated logo ... RHHBY), approved for use with Roche's cobas® HPV test in May 2024. Interested patients can opt for self-collection in clinical settings, such as a ...